No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma

Neuropathology and Applied Neurobiology

Volumn 30, Issue 3, 2004, Pages 304-307

  Mueller, W ^a   David Eum, J H ^a   Lass U ^a   Paulus, W ^b   Sarkar, C ^c   Bruck, W ^d   Von Deimling, A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Choroid plexus papilloma; hSNF5 INI1; Mutation

Indexed keywords

FORMALDEHYDE;

ARTICLE; CHOROID PLEXUS PAPILLOMA; CHROMOSOME 22Q; EXON; GENE; GENE FUNCTION; GENE MUTATION; HSNF 5 GENE; HUMAN; HUMAN TISSUE; INI 1 GENE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CHOROID PLEXUS NEOPLASMS; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, PAIR 22; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONS; HUMANS; PAPILLOMA, CHOROID PLEXUS; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TISSUE FIXATION; TRANSCRIPTION FACTORS;

EID: 2942731532     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2004.00538.x     Document Type: Article

References (22)

1. Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System. 1. Lyon: IARC Press 2000
2. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999; 65: 1342-8
3. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 2000; 66: 1403-6
4. Weber M, Stockhammer F, Schmitz U, von Deimling A. Mutational analysis of INI1 in sporadic human brain tumors. Acta Neuropathologica 2001; 101: 479-82
5. Armstrong JA, Bicker JJ, Emerson BM. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 1998; 95: 93-104
6. Biggar SR, Crabtree GR. Continuous and widespread roles for the Swi-Snf complex in transcription. Embo J 1999; 18: 2254-64
7. Phelan ML, Sif S, Narlikar GJ, Kingston RE. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 1999; 3: 247-53
8. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo J 1996; 15: 5370-82
9. Biegel JA, Fogelgren B, Zhou JY, James CD, Janss AJ, Allen JC, Zagzag D, Raffel C, Rorke LB. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res 2000; 6: 2759-63
10. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002; 8: 3461-7
11. Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res 1999; 59: 3152-6
12. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998; 394: 203-6
13. Versteege I, Medjkane S, Rouillard D, Delattre O. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene 2002; 21: 6403-12
14. Rickert CH, Wiestler OD, Paulus W. Chromosomal imbalances in choroid plexus tumors. Am J Pathol 2002; 160: 1105-13
15. von Deimling A, Bender B, Louis DN, Wiestler OD. A rapid and non radioactive PCR based assay for the detection of allelic loss in human gliomas. Neuropathol Appl Neurobiol 1993; 19: 524-9
16. Frayling IM. Methods of molecular analysis: mutation detection in solid tumours. Mol Pathol 2002; 55: 73-9
17. Nataraj AJ, Olivos-Glander I, Kusukawa N, Highsmith WE Jr. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis 1999; 20: 1177-85
18. Schmitz U, Mueller W, Weber M, Sevenet N, Delattre O, von Deimling A. INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 2001; 84: 199-201
19. Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minna JD, Sone S, Yokota J. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci USA 2002; 99: 12269-74
20. Rutherford J, Chu CE, Duddy PM, Charlton RS, Chumas P, Taylor GR, Lu X, Barnes DM, Camplejohn RS. Investigations on a clinically and functionally unusual and novel germline p53 mutation. Br J Cancer 2002; 86: 1592-6
21. Vital A, Bringuier PP, Huang H, San Galli F, Rivel J, Ansoborlo S, Cazauran JM, Taillandier L, Kleihues P, Ohgaki H. Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol 1998; 57: 1061-9
22. Jay V, Ho M, Chan F, Malkin D. P53 expression in choroid plexus neoplasms: an immunohistochemical study. Arch Pathol Laboratory Med 1996; 120: 1061-5